search
Back to results

Hospital at Home for Elderly Acute Ill Patients

Primary Purpose

Cystitis, Erysipelas, Pneumonia

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hospital at Home (HaH) treatment
Standard hospital admission
Sponsored by
Defactum, Central Denmark Region
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Cystitis

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The patient should be aged 65 and over
  • The patient should be living in their own home or a nursing home before entering the study
  • The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg)
  • The patient must have been seen by the GP or the pre-hospital service in the case of disease in question
  • The patient should speak and understand Danish.
  • The patient should give informed consent to participate in the study.

Exclusion Criteria:

  • The patient is unable to give written consent
  • The capacity of the municipal acut team care was fully utilised.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Hospital at Home (HaH) treatment

    Standard hospital admission

    Arm Description

    The patients in this arm will receive the intervention.

    The patients in this arm are the control group and will receive the standard hospital treatment.

    Outcomes

    Primary Outcome Measures

    Rate of 30-days re-admission
    Rate of 30-days re-admission after discharge
    Health Related Quality of Life
    Estimating quality of life by using EuroQoL-5 Dimensions. We will use EuroQoL-5 Dimensions to measure Health Related Quality of Life. The five dimensions include mobility, self-care, usual activity, pain/discomfort and anexiety/depression.This tool will provide us with health states (11111 being the best health state and 55555 the worse health state). We will use the Danish weight to give weights to different health states obtained from EuroQoL-5 Dimensions.

    Secondary Outcome Measures

    Functional mobility test
    Estimating basic functional mobility by using Timed Up and Go (TUG)
    Mortality rate
    Estimating mortality rate for the study population using the National Registries
    Number of contacts to primary and secondary health care system
    The Danish National Registries will be used to estimate number of contacts to the primary and secondary healthcare for both control and intervention groups.

    Full Information

    First Posted
    April 21, 2022
    Last Updated
    April 29, 2022
    Sponsor
    Defactum, Central Denmark Region
    Collaborators
    Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark, Research Center for Emergency Medicine, Aarhus University, Denmark, Viborg Regional Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05360914
    Brief Title
    Hospital at Home for Elderly Acute Ill Patients
    Official Title
    Improving and Evaluation of a New Cross-sectoral Hospital at Home Model for Elderly Acute Ill Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 2022 (Anticipated)
    Primary Completion Date
    August 2024 (Anticipated)
    Study Completion Date
    August 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Defactum, Central Denmark Region
    Collaborators
    Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark, Research Center for Emergency Medicine, Aarhus University, Denmark, Viborg Regional Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.
    Detailed Description
    Background The Danish population that is above 65 years of age is expected to increase from 16% today to 25% in 2042. This will result in a larger demand for health care services, which is a task that the Danish hospital sector cannot perform alone. Emergency hospital admissions are not the best solution for treatment of all patients. For elderly, frail citizens an emergency admission is a big change in the daily life and often means a great risk of infection and delirium and loss of functional ability which takes a long time to regain. The group of elderly medical patients is a broad group that demand a coherent and cross-sectoral treatment. This patient group is often only hospitalized for a short period. The hospitalization of these patients with rather uncomplicated treatment could possibly have been prevented if the collaboration between hospital, general practitioners (GPs), pre-hospital service and municipalities had been improved further. These complex challenges underscore the need to explore innovative solutions. An alternative model of care that internationally has been identified as a possible solution is the Hospital at Home (HaH) treatment model. This model offers active treatment of a condition that otherwise would have demanded emergency admission and can be performed over a shorter period of time in patients' own home. Studies have shown that it is better for elderly patients to be treated in-home, and that patients that are treated in own home are more satisfied with their continuity of care. Many of these services are adjusted for elderly patients, but the services can be organized in different ways, focusing on different categories of patients. During the last four years, GPs, an emergency department (ED), pre-hospital service, three municipalities, as well as researchers have organized the first HaH treatment model for elderly acute ill patients in a Danish context, but it has not yet been implemented or evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment using an open labelled RCT design. Study design and setting This study was approved by the Ethical Committee, Central Denmark Region (no. 1-10-72-67-20). To qualify the patient pathway and to ensure the generalizability, we will conduct an open labelled RCT with two arms in collaboration between GPs, three municipalities (Viborg, Skive and Silkeborg), pre-hospital service, ED at the Regional Hospital, Viborg in the period between June 1, 2022, and August 31, 2024. A steering group and a task force have been established, in which all organizational units that form part of the research project are represented and actively participating. Researchers affiliated DEFACTUM, Aarhus University, and Research Center for Emergency Medicine support the cross-sectoral collaboration. The study was designed in accordance with the SPIRIT 2013 statement (Standard Protocol Items: Recommendations for Interventional Trials). Participants Patients with an acute medical condition will be invited to participate in the study. Other inclusion criteria are: The patient should be aged 65 and over The patient should be living in their own home or a nursing home before entering the study The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg) The patient must have been seen by the GP in the case of disease in question The patient should speak and understand Danish. The patient should give informed consent to participate in the study. Exclusion criteria are: The patient is unable to give written consent The capacity of the municipal acute team care was fully utilised. Randomization Patients will be identified by their GP or the referring physician (on-call or ambulance doctor). Then the GP or the referring physician (on-call or ambulance doctor) and an ED physician will jointly through a conference call evaluate whether the patient can be included in the study. The conference call is a medical assessment of the patient to ensure that patient has the criteria for the inclusion in the study. The participating patients are randomized using REDCap to the intervention group or control group, which ensures random distribution of patients in the ratio 1: 2, so that the two groups of patients are comparable. The randomisation process will be performed by the hospital visitation at ED. The investigators, patients, GPs, pre-hospital service and the ED can not influence to which group the patients will be allocated to. The ED, GP, pre-hospital service, investigators and patients will not be masked to the allocation. All patients included will receive an information booklet and get oral information about the research project. At the first visit of the acute team, the patient gets an information booklet and is informed orally about the project. Then, informed consent is obtained to get relevant information from electronic patient journal. Intervention If the patient is randomized to the intervention group, the municipalities acute teams start the treatment. The acute team can take venous blood tests, ECG and bladder scan at home. The acute team, which is available around the clock, handles the treatment at home and follows the patient closely. During the treatment course, the acute team and the ED specialist discuss the treatment process either over the phone or virtually on an iPad, where the patient is also involved. If the specialist would like to see the patient for assessment or send the patient for an X-ray, the specialist informs the acute team that the patient must go to a short check-up in the ED. Here, the specialist examines the patient himself and assesses whether the patient can continue to be treated at home, or whether the patient must be admitted to the hospital due to deterioration of the condition. The ED specialist is responsible for discharging the patient. If the patient is randomized to the control group, the patient will receive the standard hospital treatment. Power calculations An outcome in the project is the proportion of 30-days of acute hospitalization, which is an outcome that can support a power calculation for the project. Levine et al. shows that the proportion of 30-days acute hospitalization for patients who have been treated in their own home is 0.07, while for patients in the hospital it is 0.13. In order for us to show a difference in the proportion of acute readmissions with a significance level of 5% and 80% power and a ratio of 1: 2, there must be 283 patients in the control group and 566 patients in the intervention group. A total of 849 patients living in Viborg, Skive and Silkeborg Municipalities will be included in the study. Data and statistical analysis Data will be partly obtained from the Danish National Registries. Furthermore, data on resource use in HaH group, EuroQoL-5 Dimensions (EQ-5D) and the functional test Timed up and Go (TUG) will be be entered into dedicated databases and stored in accordance with the Danish Data Protection Agency requirements. Statistical analyses will be based on 'intention to treat' principles and will be performed using STATA 16. Descriptive statistics will be conducted to describe baseline variables. Logistic regression will be used to analyse the binary outcomes and the continuous outcomes will be analysed using linear regression. The results will be reported in accordance with CONSORT 2010 statement.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cystitis, Erysipelas, Pneumonia

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    849 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Hospital at Home (HaH) treatment
    Arm Type
    Experimental
    Arm Description
    The patients in this arm will receive the intervention.
    Arm Title
    Standard hospital admission
    Arm Type
    Active Comparator
    Arm Description
    The patients in this arm are the control group and will receive the standard hospital treatment.
    Intervention Type
    Other
    Intervention Name(s)
    Hospital at Home (HaH) treatment
    Intervention Description
    The intervention is a new pathway of providing acut treatment for elderly acute ill patients in their own home. If the patient is randomized to the intervention group, the municipalities acute teams start the treatment. The acute team can take venous blood tests, ECG and bladder scan at home. The acute team handles the treatment at home and follows the patient closely. During the treatment course, the acute team and the ED specialist discuss the treatment process either over the phone or virtually on an iPad, where the patient is also involved. If the specialist would like to see the patient for assessment or send the patient for an X-ray, the specialist informs the acute team that the patient must go to a short check-up in the ED. Here, the specialist examines the patient himself and assesses whether the patient can continue to be treated at home, or whether the patient must be admitted to the hospital due to deterioration of the condition.
    Intervention Type
    Other
    Intervention Name(s)
    Standard hospital admission
    Intervention Description
    The active comparator is the standard hospital admission for elderly acute ill patients.
    Primary Outcome Measure Information:
    Title
    Rate of 30-days re-admission
    Description
    Rate of 30-days re-admission after discharge
    Time Frame
    30 days period after discharge
    Title
    Health Related Quality of Life
    Description
    Estimating quality of life by using EuroQoL-5 Dimensions. We will use EuroQoL-5 Dimensions to measure Health Related Quality of Life. The five dimensions include mobility, self-care, usual activity, pain/discomfort and anexiety/depression.This tool will provide us with health states (11111 being the best health state and 55555 the worse health state). We will use the Danish weight to give weights to different health states obtained from EuroQoL-5 Dimensions.
    Time Frame
    From inclusion to 3 months follow-up
    Secondary Outcome Measure Information:
    Title
    Functional mobility test
    Description
    Estimating basic functional mobility by using Timed Up and Go (TUG)
    Time Frame
    From inclusion to 3 months follow-up
    Title
    Mortality rate
    Description
    Estimating mortality rate for the study population using the National Registries
    Time Frame
    From inclusion to 3 months follow-up
    Title
    Number of contacts to primary and secondary health care system
    Description
    The Danish National Registries will be used to estimate number of contacts to the primary and secondary healthcare for both control and intervention groups.
    Time Frame
    From inclusion to 3 months follow-up

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: The patient should be aged 65 and over The patient should be living in their own home or a nursing home before entering the study The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg) The patient must have been seen by the GP or the pre-hospital service in the case of disease in question The patient should speak and understand Danish. The patient should give informed consent to participate in the study. Exclusion Criteria: The patient is unable to give written consent The capacity of the municipal acut team care was fully utilised.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Camilla Palmhøj Nielsen, Ph.D
    Phone
    +4521621238
    Email
    camilla.palmhoj@rm.dk
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Camilla Palmhøj Nielsen, Ph.D
    Organizational Affiliation
    Defactum, Central Denmark Region
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    8417639
    Citation
    Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med. 1993 Feb 1;118(3):219-23. doi: 10.7326/0003-4819-118-3-199302010-00011.
    Results Reference
    background
    PubMed Identifier
    19170781
    Citation
    Leff B, Burton L, Mader SL, Naughton B, Burl J, Greenough WB 3rd, Guido S, Steinwachs D. Comparison of functional outcomes associated with hospital at home care and traditional acute hospital care. J Am Geriatr Soc. 2009 Feb;57(2):273-8. doi: 10.1111/j.1532-5415.2008.02103.x. Epub 2008 Dec 11.
    Results Reference
    background
    PubMed Identifier
    19507055
    Citation
    Isaia G, Astengo MA, Tibaldi V, Zanocchi M, Bardelli B, Obialero R, Tizzani A, Bo M, Moiraghi C, Molaschi M, Ricauda NA. Delirium in elderly home-treated patients: a prospective study with 6-month follow-up. Age (Dordr). 2009 Jun;31(2):109-17. doi: 10.1007/s11357-009-9086-3. Epub 2009 Jan 30.
    Results Reference
    background
    PubMed Identifier
    11791829
    Citation
    Wilson A, Wynn A, Parker H. Patient and carer satisfaction with 'hospital at home': quantitative and qualitative results from a randomised controlled trial. Br J Gen Pract. 2002 Jan;52(474):9-13.
    Results Reference
    background
    PubMed Identifier
    18179503
    Citation
    Aimonino Ricauda N, Tibaldi V, Leff B, Scarafiotti C, Marinello R, Zanocchi M, Molaschi M. Substitutive "hospital at home" versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial. J Am Geriatr Soc. 2008 Mar;56(3):493-500. doi: 10.1111/j.1532-5415.2007.01562.x. Epub 2008 Jan 4.
    Results Reference
    background
    PubMed Identifier
    16034853
    Citation
    Shepperd S, Iliffe S. Hospital at home versus in-patient hospital care. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000356. doi: 10.1002/14651858.CD000356.pub2.
    Results Reference
    background
    PubMed Identifier
    23295957
    Citation
    Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
    Results Reference
    background
    PubMed Identifier
    31842232
    Citation
    Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17.
    Results Reference
    background
    PubMed Identifier
    18843751
    Citation
    Shepperd S, Doll H, Angus RM, Clarke MJ, Iliffe S, Kalra L, Ricauda NA, Wilson AD. Admission avoidance hospital at home. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007491. doi: 10.1002/14651858.CD007491.
    Results Reference
    background
    Links:
    URL
    https://www.sst.dk/-/media/Udgivelser/2016/Styrket-indsats-for-den-aeldre-medicinske-patient.ashx?la=da&hash=8F69A91EB3B59BC7AF2ABA646A7089D99BCD660E
    Description
    The Danish National program for elderly care
    URL
    https://sum.dk/Media/A/0/Effektiv-kommunal-forebyggelse.pdf
    Description
    Effective municipality program with focus on prevention of admission and re-admission

    Learn more about this trial

    Hospital at Home for Elderly Acute Ill Patients

    We'll reach out to this number within 24 hrs